Abstract 1602P
Background
When a child has a life-limiting, irreversible condition such as advanced cancer, a healthcare team and family may decide to limit care lacking clear benefit. In such circumstances, a compassionate extubation, or discontinuation of life-sustaining ventilator support allowing natural death, may be pursued. Compassionate extubations are an infrequently performed procedure with complexities that include difficult conversations and dynamic symptom management which can lend to this being a challenging process to execute, particularly without opportunity for practice. Simulation can be a helpful tool to enhance knowledge, confidence, and preparedness with unfamiliar or uncommon scenarios in a safe environment. A compassionate extubation simulation training experience focusing on the conversational and technical skills was implemented within the Pediatric Intensive Care Unit at an academic medical center in New York City. The aim of the project was to determine whether participation in one simulation training improved healthcare providers’ confidence with performing a compassionate extubation.
Methods
A one group pretest-posttest design project was implemented using The Confidence Scale to evaluate RN and APRN confidence with performing a compassionate extubation before and after the simulation. The sample was described using descriptive statistical analysis and the Wilcoxon signed-rank test was used to evaluate for differences between first and second observations.
Results
A Wilcoxon signed-rank test determined that the compassionate extubation simulation elicited a statistically significant median increase in C-Scale scores after participation in the simulation (median = 20) compared to C-Scale scores prior (median = 12), W = 45, p = 0.007.
Conclusions
Affording opportunity for healthcare providers to sculpt and refine their practice with certain challenging clinical scenarios has been shown to improve their confidence navigating these situations. All efforts to improve confidence related to sensitive situations such as with a compassionate extubation are made with the intention of improving the experience of children at the end of their lives as well as the experiences of the families and loved ones who walk this journey with them.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1878P - Prevalence of burnout in GU oncologists in central Asia: BUCARE survey
Presenter: Oxana Shatkovskaya
Session: Poster session 05
1879P - Investigating the effect of family support on the mental health of patients with breast cancer
Presenter: Maryam Garousi
Session: Poster session 05
1880P - Cancer care: Psychoeducational intervention for first-year residents of a general hospital in northeastern Mexico
Presenter: Celia Beatriz Gonzalez-Alcorta
Session: Poster session 05
1991P - Safety and effectiveness of surgery or radiotherapy after PD-L1 Inhibitor (TQB-2450) and chemotherapy induction therapy in patients with limited-stage small cell lung cancer: A phase II trial
Presenter: Fenghuan Sun
Session: Poster session 05
1992P - A phase II safety and efficacy study of PM8002 (anti-PD-L1 x VEGF-A bispecific) combined with paclitaxel as a second-line therapy for small cell lung cancer (SCLC)
Presenter: Ying Cheng
Session: Poster session 05
1993P - Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Safety results
Presenter: Maria Dolores Isla Casado
Session: Poster session 05
1994P - Carboplatin, etoposide, bevacizumab, and atezolizumab in patients with extensive-stage SCLC – GOIRC-01-2019 CeLEBrATE ML41241 trial
Presenter: Karim Rihawi
Session: Poster session 05
1995P - Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study
Presenter: Maria Rosario Garcia Campelo
Session: Poster session 05
1996P - The impact of an etoposide shortage on patients with extensive-stage small cell lung cancer (ES-SCLC): Results of a natural experiment
Presenter: Claire Browne
Session: Poster session 05
1997P - A study of sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-disease small cell lung cancer
Presenter: Zhe-Hai Wang
Session: Poster session 05